These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1093 related articles for article (PubMed ID: 25250028)

  • 1. The intestinal microbiome in early life: health and disease.
    Arrieta MC; Stiemsma LT; Amenyogbe N; Brown EM; Finlay B
    Front Immunol; 2014; 5():427. PubMed ID: 25250028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association between Early-Life Gut Microbiota and Long-Term Health and Diseases.
    Sarkar A; Yoo JY; Valeria Ozorio Dutra S; Morgan KH; Groer M
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33504109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crucial role of early-life gut microbiota in the development of type 1 diabetes.
    Zhou H; Sun L; Zhang S; Zhao X; Gang X; Wang G
    Acta Diabetol; 2021 Mar; 58(3):249-265. PubMed ID: 32712802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysbiosis of the gut and lung microbiome has a role in asthma.
    Hufnagl K; Pali-Schöll I; Roth-Walter F; Jensen-Jarolim E
    Semin Immunopathol; 2020 Feb; 42(1):75-93. PubMed ID: 32072252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of foodborne inorganic nanoparticles on the gut microbiota-immune axis: potential consequences for host health.
    Lamas B; Martins Breyner N; Houdeau E
    Part Fibre Toxicol; 2020 Jun; 17(1):19. PubMed ID: 32487227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The possible mechanisms of the human microbiome in allergic diseases.
    Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut Microbiota Composition in Healthy Japanese Infants and Young Adults Born by C-Section.
    Nagpal R; Yamashiro Y
    Ann Nutr Metab; 2018; 73 Suppl 3():4-11. PubMed ID: 30041174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the Pediatric Gut Microbiome: Impact on Health and Disease.
    Ihekweazu FD; Versalovic J
    Am J Med Sci; 2018 Nov; 356(5):413-423. PubMed ID: 30384950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human gut microbiota/microbiome in health and diseases: a review.
    Gomaa EZ
    Antonie Van Leeuwenhoek; 2020 Dec; 113(12):2019-2040. PubMed ID: 33136284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
    Aldars-García L; Marin AC; Chaparro M; Gisbert JP
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Gut Dysbiosis in Early Life.
    Parkin K; Christophersen CT; Verhasselt V; Cooper MN; Martino D
    Microorganisms; 2021 Sep; 9(10):. PubMed ID: 34683389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influences of non-IgE-mediated cow's milk protein allergy-associated gut microbial dysbiosis on regulatory T cell-mediated intestinal immune tolerance and homeostasis.
    Wang J; Zheng S; Yang X; Huazeng B; Cheng Q
    Microb Pathog; 2021 Sep; 158():105020. PubMed ID: 34089791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease.
    Sultan S; El-Mowafy M; Elgaml A; Ahmed TAE; Hassan H; Mottawea W
    Front Physiol; 2021; 12():715506. PubMed ID: 34646151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
    Lin L; Zhang J
    BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gut microbiota: its development and relation to certain diseases].
    Sepová HK; Dudík B; Bilková A
    Ceska Slov Farm; 2018; 66(6):267-273. PubMed ID: 29623708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.